“Striking and Exciting”: Arthritis Trial Produces Results
The results of a new clinical trial have potentially pointed the way for better treatment options for rheumatoid arthritis (RA) sufferers. The antibody drug, known as tocilizumab or RoActemra, was found to be nearly four times more likely…